Evaluation of Dexametasone supplementation for ovarian responsiveness in infertile women with polycystic ovaries in IVF (ICSI cycle)
Phase 2
- Conditions
- Polycystic ovary syndrome.Polycystic ovary syndrome
- Registration Number
- IRCT201207031760N19
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
PCOs women with infertility duration less than 5 years; Age range 30-20 years. Exclusion criteria: Women with uterine problems such as Uterine fibroids and internal septa; Endometriosis; Women with a history of ovarian or ovarian surgery; The problem of male infertility.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: The detection of fetal heartbeat, two weeks after being tested positive for HCG. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method The number of embryos obtained. Timepoint: On the third day after the oocyte Removal. Method of measurement: Ultrasound.;Number of oocytes. Timepoint: 36-34 h after HCG injection. Method of measurement: Ultrasound.;Gonadotropin dose. Timepoint: The third day of the next menstrual cycle. Method of measurement: Clinical.